OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro and in vivo assessment of the antioxidant potential of isoxazole derivatives
Mohammed Hawash, Nidal Jaradat, Murad Abualhasan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents
İrfan Çapan, Mohammed Hawash, Mohammed T. Qaoud, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 22

Assessing the therapeutic potential and safety of traditional anti-obesity herbal blends in Palestine
Mohammed Hawash, Nidal Jaradat, Nihal Ayman Salhi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Multi-biological activity assessment and phytochemical characterization of an aqueous extract of the Cymbopogon citratus grown in Palestine
Belal Rahhal, Mohammad Qneibi, Nidal Jaradat, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

In silico assessments, Design, synthesis, and biological evaluation of 5-methylisoxazole-4-carboxamide derivatives
Pravin Khedkar, Rutuja Ukhade, Hemchandra K. Chaudhari
Journal of the Indian Chemical Society (2025), pp. 101616-101616
Closed Access

Cannabis sativa L. essential oil: Chemical composition, anti-oxidant, anti-microbial properties, and acute toxicity: In vitro, in vivo, and in silico study
Rafik El-Mernissi, Naoual El Menyiy, Rania Moubachir, et al.
Open Chemistry (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies
Rachid Bouzammit, Salim Belchkar, Mohamed El fadili, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2510-2510
Open Access | Times Cited: 3

Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents
Samuel Boateng, Tithi Roy, Kara Torrey, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9

Targeting hematological malignancies with isoxazole derivatives
Monika Majirská, Martina Bago Pilátová, Z Kudlicková, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104059-104059
Open Access | Times Cited: 2

Access to Isoxazoles via Photo-oxygenation of Furan Tethered α-Azidoketones
Uma Devi Newar, Sylvia Jaya Kumar, Anupriya Borah, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 17, pp. 12378-12386
Closed Access | Times Cited: 1

Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules
Agata Paneth, Barbara Kaproń, Tomasz Plech, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17521-17521
Open Access | Times Cited: 3

SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Étienne De Braekeleer, et al.
(2024)
Open Access

SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Étienne De Braekeleer, et al.
eLife (2024) Vol. 12
Open Access

Exploring the Diverse Biological Frontiers of Isoxazole: A Comprehensive Review of its Pharmacological Significance
Yogesh Shinde, Bhushan Khairnar, Sachin Bangale
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access

A novel class of potent antiangiogenic and antioxidant pyrazoles: synthesis, bioactivity, docking and ADMET studies
Siddaram Nadigar, Rohith Gattu, S. R. Ramesh, et al.
Future Medicinal Chemistry (2024), pp. 1-16
Closed Access

Isoxazole compounds: unveiling the synthetic strategy, In-silico SAR & Toxicity studies and future perspective as PARP inhibitor in cancer therapy
Udita Malik, Dilipkumar Pal
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116898-116898
Closed Access

Green synthesis, characterization & biological evaluation of 3,5-diphenyl isoxazole derivatives
Santanu Kumar Hotta, Akshita Panigrahi, Abhisek Maharana, et al.
Journal of Innovations in Applied Pharmaceutical Science (JIAPS) (2024), pp. 1-6
Open Access

Оценка влияния матрицы на результаты потенциометрического определения антиоксидантной емкости
Е. Л. Герасимова, Elena Salimgareeva, Е. А. Елтышева, et al.
Журнал аналитической химии (2024) Vol. 79, Iss. 1, pp. 24-33
Closed Access

Targeting JNK kinase inhibitors via molecular docking: A promising strategy to address tumorigenesis and drug resistance
Samar Sami AlKafaas, Sohila A. Khedr, Sara Samy Elkafas, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107776-107776
Closed Access

Integrative bioinformatic and experimental analysis of benzoylbenzodioxol derivatives: hypoglycemic potential in diabetic mice
Mohammed Hawash, Nidal Jaradat, Murad Abualhasan, et al.
3 Biotech (2024) Vol. 14, Iss. 10
Closed Access

SOD1is a synthetic lethal target inPPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Étienne De Braekeleer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Étienne De Braekeleer, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top